Shandong Weigao Medical Polymer Net Income 2012-2024 | SHWGF
Shandong Weigao Medical Polymer net income from 2012 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
| Shandong Weigao Medical Polymer Annual Net Income (Millions of US $) |
|
|---|---|
| 2023 | $283 |
| 2022 | $405 |
| 2021 | $348 |
| 2020 | $294 |
| 2019 | $267 |
| 2018 | $223 |
| 2017 | $256 |
| 2016 | $166 |
| 2015 | $177 |
| 2014 | $176 |
| 2013 | $63 |
| 2012 | $158 |
| 2011 | $538 |
| Shandong Weigao Medical Polymer Quarterly Net Income (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| 2014-06-30 | $41 |
| 2013-12-31 | |
| 2013-06-30 | $33 |
| 2012-12-31 | |
| 2012-06-30 | $45 |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.459B | $1.821B |
| Shandong Weigao Group Medical Polymer Company Limited is engaged in the research and development, production, and sale of single-use medical devices. Single use products offered by the Company includes syringes, blood bags and blood component segregator consumables, blood sampling products, dental and anesthetic consumables, and prefilled syringes for pre-pack medication and etc. It also offers orthopedic materials and instruments like trauma products of steel plates and screws, spinal implants, and artificial joints; blood purification consumables, such as puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers, PVC granules, and related consumables, as well as immunity adsorption products for the treatment of immune system diseases; and cardiovascular stents, including drug eluting stents and balloons. Shandong Weigao Group Medical Polymer Company is based in Weihai, the People's Republic of China. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.390B | 27.94 |
| Boston Scientific (BSX) | United States | $154.114B | 38.58 |
| Stryker (SYK) | United States | $145.370B | 30.40 |
| EssilorLuxottica (ESLOY) | France | $128.999B | 0.00 |
| Medtronic (MDT) | Ireland | $107.400B | 15.23 |
| Haleon (HLN) | United Kingdom | $51.375B | 29.26 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.537B | 0.00 |
| ResMed (RMD) | United States | $35.781B | 26.88 |
| GE HealthCare Technologies (GEHC) | United States | $32.121B | 15.25 |
| Agilent Technologies (A) | United States | $31.661B | 20.57 |
| Terumo (TRUMY) | Japan | $27.316B | 35.48 |
| Insulet (PODD) | United States | $22.872B | 89.78 |
| Koninklijke Philips (PHG) | Netherlands | $21.440B | 15.41 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.026B | 11.58 |
| Baxter (BAX) | United States | $15.164B | 11.32 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.767B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $5.893B | 20.51 |
| Lantheus Holdings (LNTH) | United States | $5.336B | 13.46 |
| Prestige Consumer Healthcare (PBH) | United States | $4.224B | 18.87 |
| Perrigo (PRGO) | Ireland | $3.672B | 9.31 |
| Haemonetics (HAE) | United States | $3.304B | 15.05 |
| ICU Medical (ICUI) | United States | $3.213B | 23.69 |
| Envista Holdings (NVST) | United States | $3.068B | 25.49 |
| GN Store Nord (GNNDY) | Denmark | $2.170B | 17.98 |
| QuidelOrtho (QDEL) | United States | $2.005B | 13.79 |
| LeMaitre Vascular (LMAT) | United States | $1.817B | 40.61 |
| AtriCure (ATRC) | United States | $1.683B | 0.00 |
| Acuren (TIC) | United States | $1.297B | 0.00 |
| Neogen (NEOG) | United States | $1.235B | 15.81 |
| AdaptHealth (AHCO) | United States | $1.181B | 11.99 |
| Green Thumb Industries (GTBIF) | United States | $1.143B | 25.71 |
| Kestra Medical Technologies (KMTS) | United States | $1.062B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 12.74 |
| BioLife Solutions (BLFS) | United States | $0.983B | 0.00 |
| InMode (INMD) | Israel | $0.907B | 9.14 |
| Evolus (EOLS) | United States | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.621B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.549B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.536B | 0.00 |
| Owens & Minor (OMI) | United States | $0.491B | 4.07 |
| Capricor Therapeutics (CAPR) | United States | $0.466B | 0.00 |
| Surmodics (SRDX) | United States | $0.421B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.410B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.316B | 11.61 |
| Aurora Cannabis (ACB) | Canada | $0.293B | 52.10 |
| Cresco Labs (CRLBF) | United States | $0.289B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.259B | 21.87 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Cerus (CERS) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.40 |
| Verano Holdings (VRNOF) | United States | $0.226B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.222B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.213B | 0.00 |
| Quanterix (QTRX) | United States | $0.204B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.197B | 0.00 |
| Biote (BTMD) | United States | $0.194B | 5.45 |
| Brainsway (BWAY) | Israel | $0.193B | 51.10 |
| High Tide (HITI) | Canada | $0.186B | 0.00 |
| Omeros (OMER) | United States | $0.180B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.178B | 14.48 |
| Organigram Global (OGI) | Canada | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.152B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.139B | 17.12 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Agape ATP (ATPC) | $0.080B | 0.00 | |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.061B | 0.00 |
| Zynex (ZYXI) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.054B | 0.00 |
| United Health Products (UEEC) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.29 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Nephros (NEPH) | United States | $0.033B | 44.71 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Safety Shot (SHOT) | United States | $0.020B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |